v3.26.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Assets    
Cash $ 1,424,426 $ 3,378,152
Digital assets - current (Note 4) 2,563,474 9,021,927
Finance receivables 17,533 21,051
Marketable securities (Note 7) 37,380 27,050
Receivable from sale of Symbiont assets (Note 7) 0 200,000
Prepaid expenses and other assets 1,198,486 827,237
Digital assets - collateral (Note 4) 5,500,000 0
Digital assets receivable, net (Note 4) 12,678,014 0
Galaxy loan derivative (Note 8) 47,673 0
Income tax receivable 31,187 31,187
Current assets 23,498,173 13,506,604
Fixed assets, net (Note 5) 9,917,350 18,376,948
Intangible assets, net (Note 5) 6,327,769 5,478,958
Deposit on mining equipment (Note 6) 1,597 467,172
Long-term investments - equity securities (Note 7) 233 4,255
Investment in Seastar Medical Holding Corporation (Note 7) $ 24,840 $ 200,790
Investment, Issuer Affiliation [Extensible Enumeration] us-gaap:InvestmentAffiliatedIssuerMember us-gaap:InvestmentAffiliatedIssuerMember
Digital assets - long-term (Note 4) $ 8,233,035 $ 0
Digital assets - collateral (Note 4) 2,200,000 5,000,000
Right of use assets (Note 9) 728,995 938,641
Other assets 384,234 73,857
Long-term assets 27,818,053 30,540,621
Total assets 51,316,226 44,047,225
Liabilities and stockholders' equity    
Accounts payable and accrued expenses 1,745,875 989,563
Note payable - short-term (Note 8) 7,006,912 386,312
Master digital currency loan (Note 8) 10,920,838 0
Due to related parties (Note 11) $ 48,319 $ 15,944
Other Liability, Current, Related Party [Extensible Enumeration] Related Party [Member] Related Party [Member]
Current portion of lease liability (Note 9) $ 194,618 $ 170,967
Total current liabilities 19,916,562 1,562,786
Note payable - long-term (Note 8) 1,932,502 6,365,345
Lease liability - net of current portion (Note 9) 590,368 776,535
Long-term liabilities 2,522,870 7,141,880
Total liabilities 22,439,432 8,704,666
Stockholders' equity (Note 12)    
Preferred stock, par value $.001; 150,000,000 shares authorized; no shares issued and outstanding as of December 31, 2025 and December 31, 2024
Common stock, par value $.001; 350,000,000 shares authorized; 14,123,497 and 5,133,412 shares issued and outstanding as of December 31, 2025 and December 31, 2024 13,592 4,602
Additional paid-in capital 123,186,921 102,685,470
Accumulated deficit (92,582,928) (65,662,731)
Total LM Funding America stockholders' equity 30,617,585 37,027,341
Non-controlling interest (1,740,791) (1,684,782)
Total stockholders' equity 28,876,794 35,342,559
Total liabilities and stockholders’ equity $ 51,316,226 $ 44,047,225

Source

HTML PDF
ZIP